“…Second, individual subjects confirmed to be gene carriers and non-carriers should perform those tasks and their performance should be compared to that of healthy control samples, on the assumption that only the former should evince the deficits documented herein. The necessary analysis could be performed, for example, through Crawford's modified two-tailed t-test (Crawford & Garthwaite, 2002, 2012Crawford, Garthwaite, & Howell, 2009;Crawford, Garthwaite, & Ryan, 2011;Crawford & Howell, 1998), which proves robust for non-normal distributions, presents low rates of type-I error, and has been successfully used in previous single-case studies (Couto et al, 2013(Couto et al, , 2014Garc ıa, Sedeño, Herrera Murcia, Couto, & Ib añez, 2017;Garc ıa, Abrevaya, et al, 2017;Straube et al, 2010). The evidence thus obtained would be critical to test the usefulness of the proposed domains to detect pre-clinical deficits at the singlesubject level.…”